ABSTRACT
Nuclear medicine hybrid imaging (PET/CT and SPECT/CT) has undergone several technological advances over the past decade. This lecture will review the evolution of hybrid imaging and describe the technological advances in the field from system design to image generation and data analysis tools. The lecture will cover innovations in detector design, resolution recovery, time of flight imaging, quantitative evaluation, attenuation correction, and reconstruction algorithms. The lecture will also cover PET/MR imaging and its current challenges and opportunities. 
This session summarizes the highlights of the 2014 AAPM Summer School on SRS/SBRT. The first speaker will highlight critical anatomical structures which physicists and treatment planners need to be aware of in SRS/SBRT. Contouring atlases specific to SRS/SBRT are discussed, e.g. the consensus guidelines published by the spine consortium.The second lecture focuses on the physics of small field dosimetry, which is a special skill set within the field of clinical medical physics. The state-of-the art recommendation on detector selection and measurement techniques will be discussed, including current recommendations on the use of detector correction factors.The third speaker will summarize treatment planning approaches specific to classic SRS/SBRT targets in the brain, lung, GI and GU regions. The appropriate use of respiratory management techniques for SBRT in lung, liver and pancreas requires the careful and considerate application of complex technology. Current society recommendations and peerreviewed literature on accepted approaches to respiratory motion management will be summarized.In the last decade, the selection of treatment machines capable of delivering SRS/SBRT treatments with the required spatial and dosimetric accuracy has increased significantly. The speaker will discuss the major technical components of each delivery device, highlighting strength and weaknesses of each system as they apply to SRS/SBRT.SRS/SBRT delivers a high dose with steep dose gradients in 1-5 fractions, using complex technology with image guidance. Both the risk of error and the impact of errors is amplified under these circumstances. The last speaker of this session will discuss selected case reports of errors, including a root cause analysis. Current safety initiatives and recommendations for improved safety practices will be introduced. Resources to guide safe and effective implementation of an SRS/SBRT program will be discussed and shared with the audience. 
Sub-Events
Participants Andrew England, PhD, Salford, United Kingdom, (a.england@salford.ac.uk ) (Presenter) Nothing to Disclose LEARNING OBJECTIVES 1) Explain the rationale for optimising radiographic examinations. 2) Describe the common methods for assessing radiographic image quality and estimating radiation dose in a digital era. 3) Appraise the various methods for optimising digital radiographic examinations.
ABSTRACT
Within the United Kingdom (UK) and many other countries it is a legal requirement for radiographic studies, involving humans, to use the lowest possible radiation dose whilst producing an image of acceptable quality. This practise of producing an adequate image together with the lowest possible dose is termed dose optimisation and forms part of the UK Ionising Radiation Medical Exposure Regulations. Other countries have adopted similiar practises with Image Gently and Image Wisely being examples. Making a decision regarding the adequacy of a radiographic image is largely based on visual perception. This is a highly subjective process and decisions surrounding the acceptability of radiographic images can be prone to significant observer variability.Radiographic technique is largely based around historical practises. There is a general lack of evidence regarding the most appropriate acquisition factors in order generate an optimised radiographic examination.This problem in part extends from the issue of defining an acceptable or adequate image and an overall lack of any validated methods for measuring perceptual image quality. The problem has been further exacerbated by the widespread role out of digital radiographic systems and move away from images acquired using film-screen systems. In this new arena the relationship between image quality and radiation dose has changed and the effects of changes to acquisition parameters are often poorly understood.The proposed presentation will seek to highlight current knowledge, including our own research findings, around the current methods of dose optimisation for digital radiographic examinations. This will include a short discussion on the assessment of image quality (perceptual), appropriate measures for estimating radiation dose and the various options for optimising the examination. Such options can include the adjustment of the X ray tube to detector distance, modifying the orientation of the patient, changes to the beam energy and the inclusion of additional tube filtration. In many instances acquisition factor changes can be complimentary, however, in some instances multiple changes can be counter productive and effective processes for dose optimisation are needed. 
The American Registry of Radiologic Technologists (ARRT) has instituted several changes involving education. Some of the changes have already begun and some will are slated to be phased in over the next four years. This presentation will discuss the rationale and benefits to the profession underlying these changes. It will also begin to address what R.T.s can expect from ARRT to help them successfully navigate what will be expected of them. This includes a database of academic courses and CE activities maintained by ARRT through a collaborative effort with Recognized Continuing Education Evaluation Mechanisms (RCEEMs), CE sponsors, and academic educators. The database is key to assisting R.T.s in finding education that appropriately aligns with an individual's requirement whether it be structured education for pursuing post primary certification, content-specific CE as identified by a Continuing Qualifications Requirement's assessment or discipline-specific biennial CE. 1) Understand the history of gadolinium as a contrast agent and its differing molecular structures. 2) Be familiar with the usefulness of gadolinium in a clinical environment. 3) Recognize that gadolinium chelates may have harmful effects even when used appropriately. 4) Be able to discuss the clinical decision making process of contrast utlilzation.
Gadolinium has proven its clinical effectiveness as an MRI contrast agent for over 25+ years. Thought to be harmless it was used indiscriminately for many years until the discovery of NSF in 2006. This new disease seemed to affect only those patients with poor kidney function and resulted in appropriate screening of individuals receiving gadolinium. This change in practice helped dramatically decrease cases of NSF. Gadolinium was still felt to be harmless in patients with normal renal function. Recently gadolinium has been found in the brain and tissues of patients with normal renal function challenging that notion. This course will look at this history of gadolinium and review the current research surrounding the concept of retained gadolinium in the hopes of continuing the discussion of just how helpful or harmful gadolinium might be.
